Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Development of liposome-based DNA vaccine: an effective gene delivery system for antigen presentation and innate immune activation against dendritic cells
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: MIURA, Naoya (Hokkaido University, Faculty of Pharmaceutical Sciences, Chiba City, Japan)
- Co-author(s): Naoya Miura: Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo city, Japan
Hidetaka Akita: Graduate School of Pharmaceutical Sciences, Chiba University, Chiba city, Japan
Takashi Nakamura: Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo city, Japan
Hideyoshi Harashima: Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo city, Japan
BackgroundsA DNA vaccine is one of promising vaccine strategies since engineering of the antigen is theoretically easier in comparison with other vaccine technologies. To achieve the successful DNA vaccine, delivery of the antigen-encoding gene to the antigen presenting cells and their immune-activation are both prerequisite.
AimsIn the present.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019